ALA 7.69% 18.0¢ arovella therapeutics limited

meeting, page-4

  1. 50 Posts.

    Seems they keep the goal post moving... moving... and moving.

    I hope it is a mistake, but if you look at the other time lines, they have changed those too.....
    Now the final clinial report is moved to Q3 from July 2013.
    So it will be before Sep 13 instead of July 13.

    If there is a delay, why arnt they informing shareholders the reason? Instead of changing the dates.

    Trying to keep positive, but .....
 
watchlist Created with Sketch. Add ALA (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.